Who are Larimar Therapeutics, Inc.'s main suppliers?

Larimar Therapeutics, Inc. (LRMR) key suppliers include: INDIANA-UNIVERSITY, WAKE-FOREST-UNIVERSITY-HEALTH-SCIENCES, Lexeo Therapeutics, Inc.. View the full supplier network at chainsifter.com/chain/LRMR.

Who are Larimar Therapeutics, Inc.'s major customers?

Larimar Therapeutics, Inc. (LRMR) key customers include: Lexeo Therapeutics, Inc.. View the full customer network at chainsifter.com/chain/LRMR.

What sector is Larimar Therapeutics, Inc. in?

Larimar Therapeutics, Inc. (LRMR) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

LRMR Supply Chain: Larimar Therapeutics, Inc. Supplier List & 7 Relationships

3Suppliers

1Customers

3Debt Items

7Related Chains

Larimar Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
INDIANA-UNIVERSITY	INDIANA-UNIVERSITY	92%	The Company is obligated to pay IU certain milestone payments of up to $ 2.0 million in the aggregate upon the achievement of certain developmental milestones
WAKE-FOREST-UNIVERSITY-HEALTH-SCIENCES	WAKE-FOREST-UNIVERSITY-HEALTH-SCIENCES	80%	We were previously a party to the License Agreement dated November 30, 2016, with Wake Forest University Health Sciences
LXEO	Lexeo Therapeutics, Inc.	72%	Reciprocal relationship from LXEO graph: Reciprocal relationship from LRMR graph: Reciprocal relationship from LXEO graph: Reciprocal relationship from LRMR graph: Reciprocal relationship from LXEO g…

Larimar Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
LXEO	Lexeo Therapeutics, Inc.	72%	Reciprocal relationship from LXEO graph: ply, if any, could be identified and qualified. We may be unable to find a sufficient alternative supply channel in a reasonable time or on commercially reaso…

Larimar Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
LRMR-DEBT-10796	Warrants outstanding: 628403	90%	xbrl warrant detail from xbrl 2023-08-11.
LRMR-DEBT-10797	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2012-12-31.
LRMR-DEBT	Debt stack $3.8M	90%	Market cache reports total debt of $3.8M.

Larimar Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Larimar Therapeutics, Inc..

Larimar Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
LRMR-OWNER-DEERFIELD-MANAGEMENT-COMPANY-L-P	DEERFIELD MANAGEMENT COMPANY, L.P.	90%	13F overlay lists DEERFIELD MANAGEMENT COMPANY, L.P. as top holder; 163 tracked holders.

Larimar Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
PTCT	PTC Therapeutics, Inc.	100.00	2
NBIX	Neurocrine Biosciences, Inc.	100.00	2
SLDB	Solid Biosciences Inc.	100.00	2
VYGR	Voyager Therapeutics, Inc.	100.00	2
PRME	Prime Medicine, Inc.	50.00	2
DSGN	Design Therapeutics, Inc.	50.00	2
LXEO	Lexeo Therapeutics, Inc.	36.29	1	['customer', 'supplier']

Larimar Therapeutics, Inc. Supply Chain